NextCure, Inc.
NXTC
$12.32
$0.363.01%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.42% | 67.83% | -144.24% | 5.40% | -0.55% |
| Total Depreciation and Amortization | -31.52% | -15.80% | -3.21% | -2.97% | -3.71% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -23.50% | 20.00% | -53.86% | -7.78% | 3.07% |
| Change in Net Operating Assets | -20.07% | -61.04% | 173.02% | -252.42% | 232.70% |
| Cash from Operations | -21.86% | 72.40% | -74.80% | -86.45% | 39.16% |
| Capital Expenditure | -- | -- | -- | -- | 120.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -31.00% | 131.44% | -47.01% | 2.46% | -62.53% |
| Cash from Investing | -31.00% | 131.44% | -47.01% | 1.95% | -61.99% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -100.00% | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 667.19% | 114.36% | -187.03% | -22,792.31% | -99.62% |